Skip to content

Clinical trials

Completed Pancreatic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pancreatic Neoplasms Status: Completed Country / region: Taiwan Clear all

34 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20051
20071
20081
20094
20112
20131
20143
20151
20162
20174
20184
20191
20202
20223
20241
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed34

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company4
National Health Research Institutes, Taiwan3
Hoffmann-La Roche2
Sumitomo Pharma America, Inc.2
Taipei Veterans General Hospital, Taiwan2
Acepodia Biotech, Inc.1
Astellas Pharma Global Development, Inc.1
Boehringer Ingelheim1
Celgene1
Exelixis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pancreatic Neoplasms34
Neoplasms9
Breast Neoplasms5
Neoplasm Metastasis5
Colorectal Neoplasms4
Ovarian Neoplasms4
Adenocarcinoma3
Biliary Tract Neoplasms3
Carcinoma, Non-Small-Cell Lung3
Digestive System Diseases3

Trials

Showing 1 to 25 of 34. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.